glp-1 agonists cardiovascular diseases receptor (GLP-1RAs): actions and therapeutic potential Glucagon-like peptide 1 receptor agonists:
Description
TrimBody M.D

For maximum effectiveness, retatrutide may surpass tirzepatide but is not yet FDA-approved

M., Szczepanski, L
Some patients may experience symptoms such as nausea, vomiting, diarrhea, and constipation

doi: 10.1152/physrev.00013.2014

N Engl J Med (1992) 326:131622
